Tumor antigens are often also expressed by normal cells; therefore, tumor antigen specific immunotherapy could cause destruction of normal tissues. Modulation of immune responses using inducible gene therapy vectors allows tightly regulating these functions to reduce the risk of auto-immunity development. For details, see Curtin et al. in this issue.